Start a free trial
Menu

STANAG 7165

STANAG 7165 initial investigation and management of laser eye damage in aircrew

Defence organisations, and their medical equipment or training suppliers, working to a contract that invokes STANAG 7165 or the AAMedP-1.9 publication it covers

STANAG 7165 is NATO's ratification agreement bringing AAMedP-1.9, Edition C - aeromedical guidance on investigating and managing laser eye damage in aircrew - into force among participating nations.

Edition
4
Published
2025-09-05

What it is

STANAG 7165 is the NATO Standardization Agreement covering the initial investigation and immediate management of laser eye damage in aircrew. It is the agreement, not the medical guidance itself: this is Edition 4, promulgated 5 September 2025, superseding Edition 3 of 11 November 2019, and it brings AAMedP-1.9, Edition C, into force for the nations that ratify it.

A STANAG is not the medical guidance

A STANAG is the agreement by which NATO nations commit to implement a standard, not the technical or clinical content itself. STANAG 7165's own text is short: a letter of promulgation, an aim, a single-line agreement, and the ratification and implementation machinery. The actual investigation and management steps for laser eye damage are set out in a separate publication, AAMedP-1.9, Edition C, which the STANAG names as the standard participating nations "agree to implement". Anyone actually investigating or managing a case needs AAMedP-1.9's own text, not this cover agreement.

What it commits nations to

The stated aim is "to respond to the following interoperability requirements", which the document gives as standardizing "the initial investigation and management of LASER eye damage in aircrew in order to facilitate medical assurance of practice and enhance interoperability". The current edition is a significant revision of the one it replaces: the letter of promulgation says AAMedP-1.9, Edition C "has been significantly revised from Edition B and must be read in its entirety", with its contents reordered and its format updated. STANAG 7165 lists no other related documents and supersedes "STANAG 7165, Edition 3, dated 11 November 2019".

Who it binds, and how

STANAG 7165 binds nations, not suppliers. It is effective "upon receipt for use by the participating nations and NATO bodies", and it becomes binding on a given nation through ratification, which NATO records in the NATO Standardization Documents Database (NSDD). Implementation is a separate, further step: AAMedP-1.9 is "considered implemented when the entity has updated its procedures regarding the investigation of laser eye damage in aircrew and its medical personnel is able to act according to the provision of the present standard". In practical terms the document expects an implementing entity to update its own procedure, update and deliver training for the relevant medical personnel, train those personnel, and acquire and make available the equipment the standard calls for; the clinical detail behind each of those steps sits in AAMedP-1.9 itself. Allied nations and NATO bodies are then obliged to report implementation details through NATO's electronic reporting tool; partner nations are only invited to do the same. The STANAG names no NATO-wide effective date (its own "NATO EFFECTIVE DATE (NED)" field reads "Not applicable"), and the document itself sets no obligation reaching a supplier directly - a supplier meets it, or the AAMedP-1.9 guidance it covers, only where a contract says so.

How it's evaluated

STANAG 7165 describes no certification scheme and no audit. What it describes is nations reporting their ratification and implementation status to NATO for the record; nobody is "STANAG 7165 certified", and the document never uses that language. Review of the STANAG itself runs "in accordance with AAP-03", with the result recorded in the NSDD. It is supervised under the Military Committee's Air Standardization Board, through its Aeromedical Working Group.

Standards it references

STANAG 7165 covers AAMedP-1.9, the Allied Medical Publication that carries the actual investigation and management guidance; participating nations agree to implement it by name. Reviews of the STANAG itself, and the format the current edition of AAMedP-1.9 follows, both point to AAP-03.

How we help

Investigating and managing a case of laser eye damage in aircrew is done by trained medical personnel, working to AAMedP-1.9 itself, not in a compliance platform. Implementing STANAG 7165 is the surrounding organisational work: updating the relevant procedure, updating and delivering training for the medical personnel involved, training them, and holding the equipment the standard calls for.

What ComplyTrain does for that kind of work generally is give an organisation supporting an aeromedical function one auditable place to hold those procedures, the training records for the people involved, and the evidence trail - reviews, corrective actions, document control - that a government quality representative or an internal review would ask to see.

ComplyTrain does not investigate or manage a laser eye injury, examine an aircrew member, or decide whether a case has been handled to AAMedP-1.9's own requirements. That is clinical work, carried out by trained medical personnel against the publication itself.

Which STANAGs and Allied Publications actually apply to a given aeromedical programme is set by the contract and the customer's quality clause, not by us. Browse the explorer to see what sits alongside STANAG 7165 and AAMedP-1.9, and talk to us about the evidence trail once you know which ones are in your contract.

Standards it references

Questions

Is STANAG 7165 mandatory?

Only where a nation has ratified and implemented it, and it reaches a supplier only where a contract says so. The STANAG's own "NATO EFFECTIVE DATE (NED)" field reads "Not applicable", so there is no blanket start date to point to.

What is the difference between STANAG 7165 and AAMedP-1.9?

STANAG 7165 is the NATO ratification agreement; AAMedP-1.9, Edition C is the publication that actually sets out the investigation and management guidance. Ratifying STANAG 7165 is how a nation commits to implement AAMedP-1.9.

Can a company be certified to STANAG 7165?

No. STANAG 7165 describes nations ratifying and reporting implementation to NATO, recorded in the NATO Standardization Documents Database. It names no certification or audit scheme for a supplier or a product.

What changed in this edition of AAMedP-1.9?

The letter of promulgation states that this edition "has been significantly revised from Edition B and must be read in its entirety", with its contents reordered and its format updated. It does not set out the detail of those clinical changes here; that sits in AAMedP-1.9 itself.

Does STANAG 7165 itself contain the medical guidance?

No. It names AAMedP-1.9, Edition C as the standard participating nations "agree to implement"; the investigation and management content lives in that publication, not in this agreement.